张亮｜苏州大学｜学者主页

2026

Distinct Charge Compensation Induced by Cationic Ordering-Disordering Transition in Layered Oxide Cathode

Qianjie Niu, Chen Cheng, Zheng Zhou, Lei Wang, Pan Zeng, Liang Zhang

ACS Nano

2026

Electron Push–Pull Effect Drives Reversible Six-Electron Redox Reaction in Aqueous Zinc–Dual Halogen Batteries

Shiqi Shen, Tianran Yan, Shusheng Huang, Lei Wang, Dongniu Wang, Liang Zhang

Journal of the American Chemical Society

2026

High‐Entropy‐Tailored d − p Orbital Hybridization in Na 3 V 2 (PO 4 ) 2 O 2 F Cathodes for Durable Sodium‐Ion Batteries

Qifan Yang, Chen Cheng, Mengting Deng, Qianjie Niu, Simin Tang, Weidong Xu, Zheng Zhou, Lei Wang, Meiling Han, Yang Ling, Zengqing Zhuo, Liang Zhang

Advanced Energy Materials

2026

Ionic-Size-Dependent Reversible Interlayer Cation Migration and Voltage Hysteresis in P2-Type Sodium Layered Cathodes

Jiahao Jiao, Ze Hua, Feiran Shen, Hongjin Ren, Yi Zhou, Yilong Niu, Tianwei Cui, Yuan Wang, Haibo Bi, Yuxuan Zuo, Cheng‐Wei Kao, Ting‐Shan Chan, Zhenhua Chen, Liang Zhang, Qing Wang, He Lp, Fanghua Ning, Ruiwen Shao, Biao Li

Journal of the American Chemical Society

2025

Vacancy‐Induced In Situ Topotactic Transformation of MoS 2 for Enhanced Polyselenide Catalytic Conversion

Lei Wang, Xin Ma, Tong Chen, Yuan Cheng, Tianran Yan, Pan Zeng, Liang Zhang

Small

2025

Selectively Coordinating Solid Polymer Electrolytes Enable Nonmodified 4.6 V-LiCoO 2 for High-Capacity and Long-Cycling Lithium Batteries

Lingfei Tang, Li Qiang, Xiaoxuan Liu, Yawen Xie, Liang Zhang, Yixiao Zhang, Qinfeng Zheng, Chang‐Qi Ma, Qi Chen, Liwei Chen

ACS Energy Letters

2025

Atmospheric Corrosion-Driven Redox Coordination Enables Spontaneous Carbonate Conversion of Lithium-Ion Battery Cathodes

Wendi Tang, Tianran Yan, Wenbin Dai, Kaidan Shen, Tingting Zhang, Jialong Yu, Liang Zhang, Wei Zhang

Journal of the American Chemical Society

2025

Disorder‐Induced Targeted Formation of Amorphous Lithium Sulfide for Ah‐Level Lithium–Sulfur Batteries

Lei Wang, Hongtai Li, Zhiwei Lu, Cheng Yuan, Tianran Yan, Tong Chen, Cheng Ann CHEN, Zheng Zhou, Liang Zhang

Advanced Functional Materials

2025

Revealing the Degradation Mechanism of Lithium‐Ion Batteries for Electric Aircraft

S. H. Tang, Fu Sun, Hailong Wang, Qinlang Rong, Nuo Sun, Liang Zhang, Yuan Zhao, Qianjin Xiong, Bingxuan Huang, Linyu Hu, Jan‐Philipp Hoffknecht, Zhimeng Liu, Xin He

Advanced Materials

2025

Spatiotemporal Coordination-Engineered Core–Shell Zeolitic Imidazolate Frameworks Enable Self-Adaptive Electrocatalyst Reconstruction and Self-Tandem Sulfur Conversion

Hongtai Li, Lei Wang, Peng Chen, Cheng Yuan, Pan Zeng, Xiao Xia, Liang Zhang

ACS Nano

2025

Incorporating Co Nanoparticles into SiOx Anodes for High-Performance Lithium-Ion Batteries

Ling Qiang Yang, Tong Chen, Shuyuan Chen, Bin Wang, Pan Zeng, Shiqi Shen, Cheng Yuan, Zheng Gang Zhou, Jionghui Wang, Liang Zhang

ACS Applied Energy Materials

2025

Activating Transition-Metal Oxides through In Situ Regulation of Lower Hubbard Band for Catalytic Conversion of Lithium Polysulfides

Pan Zeng, Yong‐Sheng Hu, Bin Su, Xiaojuan Chen, Xiaoqin Li, Xiaofeng Zhao, Lei Wang, Genlin Liu, Wei Luo, Chen Yuan, Yingze Song, Qingyuan Wang, Liang Zhang

ACS Nano

2025

In Situ Molecular Self‐Assembly for Dendrite‐Free Aqueous Zn‐Ion Batteries

Yawen Xie, Lei Wang, Jiechang Gao, Shucheng Shi, Ni Yin, Shiqi Shen, Shusheng Huang, Tianran Yan, Yang Ling, Qi Chen, Pan Zeng, Yong Ha Han, Zhi Liu, Tiefeng Liu, Liang Zhang

Advanced Functional Materials

2025

A Bifunctional Fibrous Scaffold Implanted with Amorphous Co 2 P as both Cathodic and Anodic Stabilizer for High‐Performance Li─S Batteries

Gang Zhao, Tianran Yan, Lei Wang, Cheng Yuan, Tong Chen, Bin Wang, Chen Cheng, Pan Zeng, Yude Su, Liang Zhang

Advanced Science

2025

Cobalt-Doped Ru@RuO 2 Core–Shell Heterostructure for Efficient Acidic Water Oxidation in Low-Ru-Loading Proton Exchange Membrane Water Electrolyzers

Jinghao Chen, Yirui Ma, Cheng Chen, Tao Huang, Tao Huang, Ruihao Luo, Jingwen Xu, Xiaoyang Wang, Taoli Jiang, Hongxu Liu, Shuang Liu, Ting Huang, Ting Huang, Liang Zhang, Wei Chen

Journal of the American Chemical Society

2025

Tailoring Water‐in‐DMSO Electrolyte for Ultra‐stable Rechargeable Zinc Batteries

Huaizheng Ren, Sai Li, Liang Xu, Lei Wang, Xinxin Liu, Lei Wang, Yue Liu, Liang Zhang, Han Zhang, Yuxin Gong, Chade Lv, Dongping Chen, Jianxin Wang, Qiang Lv, Yaqiang Li, Huan Liu, Dianlong Wang, Dianlong Wang, Tao Cheng, Tao Cheng, Bo Wang, Dongliang Chao, Dongliang Chao, Shi Xue Dou

Angewandte Chemie International Edition

2024

机器无心人有心：从心-机关系再思人工智能的发展

张亮，俞泉林

《湖南科技大学学报(社会科学版)》，Vol. 27, No. 3

2024

关于“ChatGPT”的历史唯物主义三重审思

张亮

《理论探讨》，No. 3

2024

Improving ZnS Oxidation Kinetics Through Nucleophilic Regulation for High‐Performance Zinc–Sulfur Batteries

Shiqi Shen, Cheng Yuan, Yan Xu, Yawen Xie, Lei Wang, Tianran Yan, Shuyuan Chen, Liyao Wang, Tiefeng Liu, Liang Zhang

Advanced Functional Materials

2024

Reversible Oxygen Redox With Enhanced Structural Stability Through Covalency Modulation for Layered Oxide Cathodes

Shuyuan Chen, Cheng Chen, Xiao Xia, Lei Wang, Tong Chen, Yihao Shen, Xi Zhou, Weidong Xv, Zheng Zhou, Pan Zeng, Liang Zhang

Small

2024

Modulating Interfacial Zn2+ Desolvation and Transport Kinetics through Coordination Interaction toward Stable Anodes in Aqueous Zn‐Ion Batteries

Jiechang Gao, Yawen Xie, Lei Wang, Pan Zeng, Liang Zhang

Small

2024

Tuning Adsorbate‐Mediated Strong Metal‐Support Interaction by Oxygen Vacancy: A Case Study in Ru/TiO2

Juan Li, Lin Zhang, Xingda An, Kai Ming Feng, Xuchun Wang, Jiari He, Yang Huang, Jingjing Liu, Liang Zhang, Binhang Yan, Chaoran Li, Le He

Angewandte Chemie

2024

Chemomechanics Engineering Promotes the Catalytic Activity of Spinel Oxides for Sulfur Redox Reaction

Lei Wang, Hongtai Li, Tianran Yan, Cheng Yuan, Genlin Liu, Gang Zhao, Pan Zeng, Liang Zhang

Advanced Functional Materials

2024

Cationic and Anionic Redox of Battery Cathodes Investigated by Advanced Synchrotron‐Based Mapping of Resonant Inelastic X‐ray Scattering

Chen Cheng, Zengqing Zhuo, Shuyuan Chen, Xi Zhou, Cheng Yuan, Pan Zeng, Jinghua Guo, Liang Zhang

Advanced Functional Materials

2023

阿多诺研究在中国的过去、现在与未来——纪念阿多诺诞辰120周年

张亮

《福建论坛(人文社会科学版)》，No. 9

2023

新自由主义危机时代的资本主义国家——佩里·安德森晚近政治思想评析

张亮

《东北师大学报(哲学社会科学版)》，No. 5

2023

Strategies for Optimizing the Zn Anode/Electrolyte Interfaces Toward Stable Zn‐Based Batteries

Jiechang Gao, Yawen Xie, Pan Zeng, Liang Zhang

Small Methods

2023

Electrochemical Restoration of Battery Materials Guided by Synchrotron Radiation Technology for Sustainable Lithium‐Ion Batteries

Lei Wang, Yihao Shen, Yuanlong Liu, Pan Zeng, Junxia Meng, Tiefeng Liu, Liang Zhang

Small Methods

2023

Field‐assisted electrocatalysts spark sulfur redox kinetics: From fundamentals to applications

Hongtai Li, Yanguang Li, Liang Zhang, Zhongwei Chen, Xueliang Andy Sun

Interdisciplinary materials

2023

Facile Zn 2+ Desolvation Enabled by Local Coordination Engineering for Long‐Cycling Aqueous Zinc‐Ion Batteries

Liyan Ding, Lei Wang, Jiechang Gao, Tianran Yan, Hongtai Li, Jing Mao, Fei Song, Stanislav S. Fedotov, Luo‐Yueh Chang, Ning Li, Yuefeng Su, Tiefeng Liu, Liang Zhang

Advanced Functional Materials

2023

Molecular Modulation of Sequestered Copper Sites for Efficient Electroreduction of Carbon Dioxide to Methane

Kefan Zhang, Jie Xu, Tianran Yan, Jia Horng Lin, Jie Zhang, Chaochen Shao, Liang Zhang, Na Han, Yanguang Li

Advanced Functional Materials

2023

In Situ Non‐Topotactic Reconstruction‐Induced Synergistic Active Centers for Polysulfide Cascade Catalysis

Pan Zeng, Hao Zou, Chen Cheng, Lei Wang, Cheng Yuan, Genlin Liu, Jing Mao, Ting‐Shan Chan, Qingyuan Wang, Liang Zhang

Advanced Functional Materials

2022

关于阿多诺哲学贡献的再思考——从当代中国的视角看

张亮

《北京师范大学学报(社会科学版)》，No. 3

2022

回归经典再出发的21世纪国外马克思主义

张亮

《山西大学学报(哲学社会科学版)》，Vol. 45, No. 2

2022

Cooperative Catalysis of Polysulfides in Lithium‐Sulfur Batteries through Adsorption Competition by Tuning Cationic Geometric Configuration of Dual‐active Sites in Spinel Oxides

Hongtai Li, Pei Shi, Lei Wang, Tianran Yan, Tong Guo, Xiao Xia, Chi Chen, Jing Mao, Dan Sun, Liang Zhang

Angewandte Chemie

2022

Suppressing the Dynamic Oxygen Evolution of Sodium Layered Cathodes through Synergistic Surface Dielectric Polarization and Bulk Site‐Selective Co‐Doping

Xiao Xia, Tong Liu, Chen Cheng, Hongtai Li, Tianran Yan, Haolv Hu, Yihao Shen, Huanxin Ju, Ting‐Shan Chan, Zhenwei Wu, Yuefeng Su, Yu Zhao, Duanyun Cao, Liang Zhang

Advanced Materials

2022

Ligand‐Assisted Coupling Manipulation for Efficient and Stable FAPbI3 Colloidal Quantum Dot Solar Cells

Xuliang Zhang, Hehe Huang, Lujie Jin, Chao Wen, Qian Zhao, Chenyu Zhao, Junjun Guo, Chen Cheng, Hongshuai Wang, Liang Zhang, Youyong Li, Yin Maung Maung, Jianyu Yuan, Wanli Ma

Angewandte Chemie

2022

Photothermal Catalytic Polyester Upcycling over Cobalt Single‐Site Catalyst

Yu Liu, Xuchun Wang, Qingye Li, Tianran Yan, Xiangxi Lou, Congyang Zhang, Muhan Cao, Liang Zhang, Tsun‐Kong Sham, Qiao Zhang, Le He, Jinxing Chen

Advanced Functional Materials

2022

Magnetic Field Manipulation of Tetrahedral Units in Spinel Oxides for Boosting Water Oxidation

Xiao Lyu, Ya-Nan Zhang, Zhengwei Du, Hao Chen, Sicheng Li, Alexandre I. Rykov, Chen Cheng, Weina Zhang, Ling Chang, Kai Wang, Junhu Wang, Liang Zhang, Qiang Wang, Chengxi Huang, Erjun Kan

Small

2022

Anionic Redox Activities Boosted by Aluminum Doping in Layered Sodium‐Ion Battery Electrode

Chen Cheng, Manling Ding, Tianran Yan, Jinsen Jiang, Jing Mao, Xuefei Feng, Ting‐Shan Chan, Ning Li, Liang Zhang

Small Methods

2021

卢卡奇研究在中国——基于CSSCI数据库(1998—2019)的实证分析

李灿，刘健，张亮

《山东社会科学》，No. 6

2021

坚持以人民为中心深入推进马克思主义哲学中国化

张亮

《福建师范大学学报(哲学社会科学版)》，No. 1

2021

马克思与黑格尔关系问题的"失锐式解读"——苏东剧变以来西方"马克思学"对辩证法的研究及反思

赵立，张亮

《教学与研究》，No. 4

2020

新时代的历史方位与当代国外马克思主义哲学研究的初心使命

张亮，孙乐强

《山东社会科学》，No. 5

2020

从虚拟世界“道”人工智能——马克思主义哲学视域下“人机关系”的时代反思与批判

张亮

《海南大学学报(人文社会科学版)》，Vol. 38, No. 4

2020

虚拟世界“人机”关系之“三维”图景新论

张亮，章珺

《重庆理工大学学报：社会科学》，Vol. 34, No. 1

2020

英国马克思主义关于当代工人阶级的争论及其理论反思

张亮

《福建论坛(人文社会科学版)》，No. 6

2020

Alloyed Palladium–Silver Nanowires Enabling Ultrastable Carbon Dioxide Reduction to Formate

Na Han, Mingzi Sun, Yuan Zhou, Jie Xu, Chen Cheng, Rui Zhou, Liang Zhang, Jun Luo, Bolong Huang, Yanguang Li

Advanced Materials

2020

Detailed Characterization of an Annealed Reduced Graphene Oxide Catalyst for Selective Peroxide Formation Activity

Tae Hoon Lee, Sojung Park, Tae Hwan Choi, Liang Zhang, Ju‐Young Kim, Jinghua Guo, Ho Bum Park, Wooyul Kim, Hyo Won Kim

ACS Applied Materials & Interfaces

2020

Abstract 652: Exploiting PRMT5, a metabolic and epigenetic regulator, as a novel therapeutic target in mantle cell lymphoma

Yi-Xin Yao, Ling-Zhi Li, Liang Zhang, Shao-Jun Zhang, Hui Guo, Hui Zhang, M. Badillo, Zhi-Hong Chen, K. Hartig, P. Jain, K. Nomie, Ling-Hua Wang, Michael L. Wang

Experimental and Molecular Therapeutics

2019

国外马克思主义哲学研究70年:回顾与展望

张亮

《武汉大学学报(哲学社会科学版)》，Vol. 72, No. 4

2019

卡弗版《德意志意识形态》:一项科学的研究成果?--对卡弗版《德意志意识形态》的批判性解读

向玉竹，张亮

《福建师范大学学报(哲学社会科学版)》，No. 5

2019

法兰克福学派与纳粹问题研究:批判的再考察

冯潇，张亮

《学术研究》，No. 12

2019

Zinc–air batteries: are they ready for prime time?

Jie Zhang, Qixing Zhou, Yawen Tang, Liang Zhang, Yanguang Li

Chemical Science

2019

Interrogating B cell signaling pathways: A quest for novel therapies for mantle cell lymphoma

Makhdum Ahmed, E. Lorence, Jeffrey Wang, Dayoung Jung, Liang Zhang, K. Nomie, Michael L. Wang

Science Signaling

2019

Tumor Microenvironment Molecular Signatures That Define Therapeutic Resistance in Mantle Cell Lymphoma

K. Nomie, N. Kotlov, V. Svekolkin, A. Bagaev, Qing-Song Cai, Jasmine Falahat, Omar Moghrabi, F. Frenkel, Ravshan Attaulakhanov, Angela Leeming, Dayoung Jung, H. Hill, K. Murfin, Zhi-Hong Chen, K. Hartig, M. Badillo, P. Jain, Liang Zhang, Michael L. Wang

Blood

2019

Frontline Treatment with Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX Is Extremely Potent and Safe in Patients (age ≤ 65 years) with Mantle Cell Lymphoma (MCL) - Results of Phase-II Window-1 Clinical Trial

Michael L. Wang, P. Jain, Hun Lee, F. Hagemeister, F. Samaniego, J. Westin, L. Nastoupil, Wendy Chen, K. Nomie, Shao-Jun Zhang, Omar Moghrabi, Shuang-Tao Zhao, R. Kanagal-Shamanna, Young-Ok Chi, O. Oriabure, G. Nogueras-González, Dayoung Jung, L. Navsaria, Annabelle Uy, A. Pedersen, Liang Zhang, Chang-Ying Jiang, Feng Lei, Yi-Xin Yao, Guo-Fan Xu, N. Wagner-Bartak, S. Thirumurthi, D. Santos, G. Tang, K. Patel, C. Yin, Michelle Avellaneda, M. Badillo, L. Fayad, S. Neelapu, N. Fowler, J. Romaguera, Ling-Hua Wang

Blood

2019

Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) - Response and Clinical Outcomes in Ultra-Refractory MCL

P. Jain, Shuang-Tao Zhao, R. Kanagal-Shamanna, L. Navsaria, H. Hill, Ankita Misra, K. Nomie, Chang-Ying Jiang, Yi-Xin Yao, Liang Zhang, L. Nastoupil, F. Hagemeister, J. Westin, R. Nair, R. Steiner, O. Oriabure, Wendy Chen, G. Tang, C. Yin, K. Patel, J. Romaguera, N. Fowler, Ling-Hua Wang, Michael L. Wang

Blood

2019

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Jeffrey Wang, Jacqueline F. Wang, E. Lopez, Hui Guo, Hui Zhang, Yang Liu, Zhi-Hong Chen, Shengjian Huang, Shou-Hao Zhou, Angela Leeming, R.-J. Zhang, Dayoung Jung, Han Shi, Hadley Grundman, D. Doakes, Kathleen Cui, Chang-Ying Jiang, Makhdum Ahmed, K. Nomie, B. Fang, Michael L. Wang, Yi-Xin Yao, Liang Zhang

Blood Cancer Journal

2019

Molecular Profiling plus In Vitro and In Vivo Drug Efficacy Analyses Identifies Novel Treatments to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Yang Liu, K. Nomie, Chang-Ying Jiang, Yi-Xin Yao, Liang Zhang, Michael L. Wang

Clinical Lymphoma, Myeloma & Leukemia

2019

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

Liang Zhang, Yi-Xin Yao, Shao-Jun Zhang, Yang Liu, Hui Guo, Makhdum Ahmed, T. Bell, Hui Zhang, Guangchun Han, E. Lorence, M. Badillo, Shou-Hao Zhou, Yu-Ting Sun, M. D. Di Francesco, N. Feng, R. Haun, R. Lan, Samuel G. Mackintosh, X. Mao, Xing-Zhi Song, Jian-Hua Zhang, L. Pham, P. Lorenzi, J. Marszalek, Timmothy Heffernan, G. Draetta, P. Jones, A. Futreal, K. Nomie, Ling-Hua Wang, Michael L. Wang

Science Translational Medicine

2019

Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Liang Zhang, Hui Guo, Hui Zhang, Yi-Xin Yao, Yang Liu, Shao-Jun Zhang, L. Rui, Ling-Hua Wang, K. Nomie, Michael L. Wang

Blood

2019

Identify AMPK-Mediated Autophagy and Oxphos As a Novel Metabolic Vulnerability for Targeted Therapy in Mantle Cell Lymphoma

Yi-Xin Yao, Yang Liu, Hui Zhang, Angela Leeming, J. McIntosh, P. Jain, Liang Zhang, K. Nomie, Michael L. Wang

Blood

2019

The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Yang Liu, Shuang-Tao Zhao, Chang-Ying Jiang, Yi-Xin Yao, K. Murfin, Hadley Grundman, Liang Zhang, K. Nomie, Ling-Hua Wang, Michael L. Wang

Blood

2019

Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial

P. Jain, Hun Lee, R. Steiner, F. Hagemeister, F. Samaniego, J. Westin, L. Nastoupil, Saira S. Ahmed, S. Iyer, J. Romaguera, Shuang-Tao Zhao, K. Nomie, Young-Ok Chi, R. Kanagal-Shamanna, O. Oriabure, Guo-Fan Xu, Liang Zhang, Chang-Ying Jiang, Dayoung Jung, L. Navsaria, Wendy Chen, Omar Moghrabi, Tayyaba Nizam, Chloe Marie McClain, M. Badillo, S. Thirumurthi, D. Santos, G. Tang, K. Patel, S. Neelapu, Ling-Hua Wang, N. Fowler, Michael L. Wang

Blood

2019

PRMT5 is upregulated by B cell receptor signaling and forms a positive feedback loop with PI3K/AKT in lymphoma cells

F. Zhu, Hui Guo, P. Bates, Shan-Xiang Zhang, Hui Zhang, K. Nomie, Yang-Guang Li, Li Lu, Kaitlyn R. Seibold, Fang-Yu Wang, Ian Rumball, Hunter Cameron, N. Hoang, David T. Yang, Wei Xu, Liang Zhang, Michael L. Wang, C. Capitini, L. Rui

Leukemia

2019

Abstract 3702: Establishment and characterization of a novelMYC/BCL2double-hit high-grade B-cell lymphoma cell line HLA-3

Hui Guo, Hui Zhang, K. Nomie, Liang Zhang, K. Murfin, Michael L. Wang

Tumor Biology

2018

西方“马克思学”研究方法的历史演替及其当代走向

张亮

《山东社会科学》，No. 1

2018

马克思与我们同在新时代——纪念马克思诞辰200周年

张亮

《武汉大学学报(哲学社会科学版)》，Vol. 71, No. 5

2018

第6届城市哲学论坛

张亮

《中国哲学年鉴》，No. 1

2018

法兰克福学派的大众文化研究

冯潇，张亮

《学术界》，No. 9

2018

“中国话语的马克思主义哲学:基本思路与建构原则”学术研讨会

张亮

《中国哲学年鉴》，No. 1

2018

Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma

Hui Guo, Dong-Feng Zeng, Hui Zhang, T. Bell, Jun Yao, Yang Liu, Shengjian Huang, Carrie J. Li, E. Lorence, Shou-Hao Zhou, Tie-Jun Gong, Chang-Ying Jiang, Makhdum Ahmed, Yi-Xin Yao, K. Nomie, Liang Zhang, Michael L. Wang

Oncogene

2018

Lee J, Zhang LL, Wu W, et al. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018;2(16):2039-2051.

Jimmy Lee, Liang Zhang, Wenjun Wu, Hui Guo, Yan Li, M. Sukhanova, G. Venkataraman, Shengjian Huang, Hui Zhang, M. Alikhan, P. Lu, A. Guo, N. Galanina, J. Andrade, Michael Wang, Y. L. Wang

Blood Advances

2018

Abstract 1981: Pan-cancer pathways gene expression profiling in mantle cell lymphoma reveals upregulation of DNA damage repair genes in ibrutinib-resistant tumor

Makhdum Ahmed, E. Lorence, Hui Guo, Shengjian Huang, V. Zhang, Hui Zhang, Liang Zhang, K. Nomie, Michael L. Wang

Experimental and Molecular Therapeutics

2018

Unravelling the Heterogeneity of Mantle Cell Lymphoma Ecosystem By Single Cell RNA Sequencing

Makhdum Ahmed, Hui Guo, Shao-Jun Zhang, L. Sehgal, P. Jain, R. Kanagal-Shamanna, Young-Ok Chi, Angela Leeming, Yi-Xin Yao, Liang Zhang, K. Nomie, Ling-Hua Wang, Michael L. Wang

Blood

2018

Simultaneous Inhibition of BCL-2 and PI3K Signaling Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma

Hai-Ge Ye, Shengjian Huang, Dayoung Jung, Chang-Ying Jiang, K. Nomie, Liang Zhang, Michael L. Wang

Blood

2018

Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

P. Jain, R. Kanagal-Shamanna, Shao-Jun Zhang, Makhdum Ahmed, A. Ghorab, Liang Zhang, Young-Ok Chi, Shao-Ying Li, F. Hagemeister, Dong-Feng Zeng, Tie-Jun Gong, Wendy Chen, M. Badillo, K. Nomie, L. Fayad, L. Medeiros, S. Neelapu, N. Fowler, J. Romaguera, R. Champlin, Ling-Hua Wang, Michael L. Wang

British Journal of Haematology

2018

Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)

P. Jain, J. Romaguera, S. Srour, Hun J. Lee, F. Hagemeister, J. Westin, L. Fayad, F. Samaniego, M. Badillo, Liang Zhang, L. Nastoupil, R. Kanagal-Shamanna, N. Fowler, Michael L. Wang

British Journal of Haematology

2018

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.

Wenjun Wu, Weige Wang, Carrie A. Franzen, Hui Guo, Jimmy Lee, Yan Li, M. Sukhanova, D. Sheng, G. Venkataraman, Ming Mei, Pin Lu, An-Hui Gao, Chun-Mei Xia, Jia Li, Liang Zhang, V. Jiang, Michael L. Wang, J. Andrade, Xiao-Yan Zhou, Y. L. Wang

Blood Advances

2018

Metabolic Profiling Identifies De Novo Nucleotide Synthesis As a Potential Metabolic Vulnerability for Targeted Therapy Against Mantle Cell Lymphoma

Yi-Xin Yao, Yang Liu, Hui Guo, Makhdum Ahmed, Shabnam Bhuiyan, K. Nomie, Liang Zhang, Michael L. Wang

Blood

2018

Research of miR-30b in Cisplatin Resistance of Human NK/T Cell Lymphoma Lines SNK-6 and YTS Cells By Targeting CCL22

R. Liang, Jian-Hong Wang, Fang Liu, Xiao-Hui Duan, Xia-Cai Hao, Liang Zhang, Michael L. Wang, Xiangxiang Liu, Yan-Hua Guo, Zhe Wang, Hailong Tang, Lj Yang

Blood

2018

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.

Jimmy Lee, Liang Zhang, Wenjun Wu, Hui Guo, Yan Li, M. Sukhanova, G. Venkataraman, Shengjian Huang, Hui Zhang, M. Alikhan, Pin Lu, A. Guo, N. Galanina, J. Andrade, Michael L. Wang, Y. L. Wang

Blood Advances

2018

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

Hui Guo, Yi-Xin Yao, Hui Zhang, E. Lorence, Makhdum Ahmed, L. Ping, K. Nomie, Liang Zhang, Michael L. Wang

Blood

2018

Pleiotropic Action of Novel Bruton’s Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma

Carrie J. Li, Chang-Ying Jiang, Yang Liu, T. Bell, Wen-Cai Ma, Yin Ye, Shengjian Huang, Hui Guo, Hui Zhang, Lai Wang, Jing Wang, K. Nomie, Liang Zhang, Michael Wang

Molecular Cancer Therapeutics

2018

Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic Reprogramming Towards Oxphos

K. Nomie, Liang Zhang, Yi-Xin Yao, Yang Liu, Shao-Jun Zhang, Hui Zhang, Hui Guo, Makhdum Ahmed, M. Badillo, Ling-Hua Wang, Michael L. Wang

Blood

2018

A Novel Patient-Derived Xenograft Model of Secondary CD20- CNS Lymphoma for Mechanistic and Therapeutic Exploration

Liang Zhang, Hui Zhang, Hui Guo, Yu-Ting Sun, N. Feng, J. Marszalek, Makhdum Ahmed, K. Nomie, Michael L. Wang

Blood

2017

斯图亚特·霍尔的理论创新道路析论

张亮

《社会科学辑刊》，No. 6

2017

《资本论》哲学的当代复兴及其哲学反思——新世纪以来相关研究动态的述评

赵立，张亮

《新视野》，No. 5

2017

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Xiaohong Zhao, T. Lwin, A. Silva, B. Shah, Jiang-Chuan Tao, B. Fang, Liang Zhang, K. Fu, Chengfeng Bi, Jian-Nong Li, Hui-Juan Jiang, M. Meads, Timothy Jacobson, Maria C. Silva, Allison Distler, L. Darville, Ling Zhang, Ying Han, Dmitri Rebatchouk, M. di Liberto, L. Moscinski, J. Koomen, W. Dalton, K. Shain, Michael L. Wang, E. Sotomayor, J. Tao

Nature Communications

2017

Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients

Chang-Ying Jiang, Shengjian Huang, Yang Liu, Carrie J. Li, Hui Guo, Jeff F. Wang, E. Lopez, Hui Zhang, E. Lorence, Maria Merolle, S. Balaji, Makhdum Ahmed, K. Nomie, Xin Lin, Liang Zhang, Michael L. Wang

2017

Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity.

Yang Liu, Yan-Zhen Yin, Zhen Zhang, Carrie J. Li, Hui Zhang, Daoguang Zhang, Chang-Ying Jiang, K. Nomie, Liang Zhang, Michael L. Wang, Gui-Sen Zhao

European journal of medicinal chemistry

2017

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.

Hun Lee, J. Romaguera, Lei Feng, A. Desai, Liang Zhang, M. Fanale, F. Samaniego, F. Hagemeister, L. Fayad, M. Rodriguez, J. Medeiros, K. Hartig, K. Nomie, Makhdum Ahmed, M. Badillo, Hai-Ge Ye, Y. Oki, P. Lin, L. Nastoupil, J. Westin, Michael L. Wang

The Oncologist

2017

Abstract 4099: Targeting the paracaspase MALT1: A potential therapy to overcome ibrutinib resistance in relapsed/refractory MCL patients

Chang-Ying Jiang, Shengjian Huang, Xin Lin, Michael L. Wang, Liang Zhang

2017

Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma

Shengjian Huang, Chang-Ying Jiang, Hui Guo, Jeff F. Wang, Yang Liu, Carrie J. Li, E. Lopez, Hui Zhang, E. Lorence, Maria Merolle, S. Balaji, Makhdum Ahmed, K. Nomie, Liang Zhang, Michael L. Wang

2017

NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells

Yang-Guang Li, Fang-Yu Wang, Li Lu, F. Zhu, Shengjian Huang, K. Nomie, Liang Zhang, David T. Yang, Wei Huang, B. Kahl, S. Safe, Michael L. Wang, L. Rui

Blood Cancer Journal

2017

BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against Mantle Cell Lymphoma cells

Baohua Sun, W. Fiskus, Y. Qian, K. Rajapakshe, Kanak Raina, K. Coleman, A. Crew, Angela Shen, Dyana T. Saenz, Christopher P. Mill, A. Nowak, N. Jain, Liang Zhang, Michael Wang, J. Khoury, C. Coarfa, C. Crews, K. Bhalla

Leukemia

2016

合目的性与合规律性的有机统一-习近平经济工作中的辩证思维

张亮

《河海大学学报(哲学社会科学版)》，Vol. 18, No. 1

2016

Patient-Derived Xenograft Model in B-Cell Lymphoma: A Platform for a Personalized Clinical Trial

T. Bell, Hui Zhang, Makhdum Ahmed, Hui Guo, Carrie J. Li, Yang Liu, L. Lam, Zhi-Hong Chen, Jack Wang, V. Zhang, K. Nomie, Liang Zhang, Michael L. Wang

2016

Discovery of 4‐(Piperazin‐1‐yl)‐7H‐pyrrolo[2,3‐d]pyrimidine Derivatives as Akt Inhibitors

Yang Liu, Yan-Zhen Yin, Jing-Ya Zhang, K. Nomie, Liang Zhang, De-Zhi Yang, Michael L. Wang, Gui-Sen Zhao

Archiv der Pharmazie

2016

Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

Yang Liu, T. Bell, Hui Zhang, Yu-Ting Sun, Carrie J. Li, N. Feng, Shengjian Huang, Hui Guo, Jack Wang, Makhdum Ahmed, V. Zhang, L. Lam, K. Nomie, Liang Zhang, M. D. Di Francesco, J. Marszalek, Michael L. Wang

2016

Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma

Carrie J. Li, Yang Liu, T. Bell, Jack Wang, Hui Guo, Makhdum Ahmed, Hui Zhang, L. Lam, K. Nomie, Lai Wang, Liang Zhang, Michael L. Wang

2016

Novel BRD4-Degrading Proteolysis Targeting Chimera (PROTACs) Exert Potent Single Agent and Synergistic Activity with Ibrutinib and Venetoclax Against Human Mantle Cell Lymphoma (MCL) Cells

K. Bhalla, Baohua Sun, W. Fiskus, Liang Zhang, Dyana T. Saenz, Christopher P. Mill, Michael L. Wang

2016

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

L. Deng, Zijun Y. Xu-Monette, S. Loghavi, G. Manyam, Yi Xia, C. Visco, J. Huh, Liang Zhang, Q. Zhai, Y. Wang, L. Qiu, K. Dybkær, A. Chiu, Anamarija M. Perry, Shan-Xiang Zhang, A. Tzankov, H. Rao, J. Abramson, A. Sohani, Mi-Na L. Xu, E. Hsi, Jian-Yu Zhu, M. Ponzoni, S. Wang, Ling Li, Ming-Zhi Zhang, A. Ferreri, B. Parsons, Yong Li, M. Piris, L. Medeiros, K. Young

Leukemia

2016

The Effects of PI3K-δ/γ Inhibitor, Duvelisib, in Mantle Cell Lymphoma in Vitro and in Patient-Derived Xenograft Studies

Jack Wang, V. Zhang, T. Bell, Yang Liu, Hui Guo, Liang Zhang

2016

Genetic and Molecular Characterization of Ibrutinib-Resistant Mantle Cell Lymphoma: Designing Innovative Therapeutic Strategies

Hui Guo, Shengjian Huang, Yang Liu, Carrie J. Li, Jack Wang, V. Zhang, Makhdum Ahmed, L. Lam, Hui Zhang, K. Nomie, Liang Zhang, Michael L. Wang

2016

Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma

Shengjian Huang, L. Nastoupil, Hui Guo, T. Bell, Makhdum Ahmed, Carrie J. Li, Jack Wang, Yang Liu, V. Zhang, Caroline R. Kim, J. Boyle, E. Lorence, L. Lam, Zhi-Hong Chen, Hui Zhang, S. Shuttleworth, K. Nomie, Michael L. Wang, Liang Zhang

2016

Novel BET Protein Proteolysis Targeting Chimeras (BETP-PROTACs) Exert Potent Single Agent and Synergistic Activity with Ibrutinib and Venetoclax Against Human Mantle Cell Lymphoma Cells

Baohua Sun, W. Fiskus, Liang Zhang, Kanak Raina, K. Coleman, J. Winkler, Y. Qian, A. Crew, Angela Shen, Dyana T. Saenz, Christopher P. Mill, Michael L. Wang, C. Crews, K. Bhalla

2016

IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay

J. Weng, Kelsey Moriarty, F. Baio, F. Chu, Sung‐Doo Kim, Jin He, Zu-Liang Jie, Xiao-Ping Xie, Wen-Cai Ma, J. Qian, Liang Zhang, Jing Yang, Q. Yi, S. Neelapu, L. Kwak

Oncoimmunology

2016

Chemotherapy-Free Induction with Ibrutinib-Rituximab Followed By Shortened Cycles of Chemo-Immunotherapy Consolidation in Young, Newly Diagnosed Mantle Cell Lymphoma Patients: A Phase II Clinical Trial

Michael L. Wang, Hun Lee, S. Thirumurthi, H. Chuang, F. Hagemeister, J. Westin, L. Fayad, F. Samaniego, F. Turturro, Wendy Chen, O. Oriabure, Steven Y. Huang, Shao-Ying Li, Liang Zhang, M. Badillo, K. Hartig, Makhdum Ahmed, K. Nomie, L. Lam, A. Addison, J. Romaguera

2016

CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model

J. Boyle, Caroline R. Kim, Hui Guo, T. Bell, Shengjian Huang, Carrie J. Li, Yang Liu, Hui Zhang, Jack Wang, V. Zhang, Makhdum Ahmed, L. Lam, K. Nomie, Liang Zhang, Dong-Feng Zeng, Michael L. Wang

2015

当马克思主义再次遭遇文化人类学：哈里斯—萨林斯之争的思想史反思

张亮

《吉林大学社会科学学报》，Vol. 55, No. 5

2015

专题：习近平闽浙时期理论著述研究--闪耀着唯物辩证法光芒的思想方法--读习近平著《之江新语》

张亮

《福建论坛(人文社会科学版)》，No. 7

2015

新常态下政府与市场辩证逻辑关系的历史性探析——习近平同志经济工作中的辩证思维研究

张亮，闫培宇张亮

《南京工业大学学报：社会科学版》，Vol. 14, No. 3

2015

《马克思恩格斯选集》收录书信的学术影响力分析——基于CSSCI数据（2002-2012）的实证研究

刘雨琦，史晨，赵立，孙乐强，张亮

《广西大学学报(哲学社会科学版)》，Vol. 37, No. 6

2015

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Bo Wang, Liang Zhang, L. Pham, Wen-Jing Tao, Hui Zhang, Jingmeng Xie, Wendy Chen, Q. Cai, D. Zou, Dong-Lu Zhao, Xiu-Hua Sun, R. Liang, Jack Wang, K. Nomie, N. Fowler, Michael L. Wang

2015

Developing Novel Therapeutic Strategies to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

L. Pham, Liang Zhang, Wen-Jing Tao, Dong-Lu Zhao, Hui Zhang, Jingmeng Xie, Jack Wang, K. Nomie, Michael L. Wang

2015

Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial

Yucai Wang, N. Wagner-Bartak, Shou-Hao Zhou, N. Fowler, Maria Lourdes Dela Rosa, Dong-Lu Zhao, J. Romaguera, S. Neelapu, F. Hagemeister, M. Fanale, Y. Oki, J. Shah, Sheeba K. Thomoas, C. Hosing, Liang Zhang, M. Badillo, Wendy Chen, Q. Cai, D. Zou, R. Champlin, L. Fayad, Hun Lee, Michael L. Wang

2015

739.full Blood W Jurczak

Michael L. Wang, K. Blum, P. Martin, A. Goy, R. Auer, B. Kahl, W. Jurczak, R. Advani, J. Romaguera, Michael E. Williams, J. Barrientos, E. Chmielowska, J. Radford, S. Stilgenbauer, M. Dreyling, W. Jędrzejczak, P. Johnson, S. Spurgeon, Liang Zhang, L. Baher, Mei Cheng, Da-Na Lee, D. Beaupre, S. Rule

2015

Pre-clinical activity of BET protein antagonist-based combinations against ibrutinib-sensitive or -resistant human Mantle Cell Lymphoma cells

Baohua Sun, W. Fiskus, Dyana T. Saenz, Stephanie S. Krieger, Liang Zhang, Michael L. Wang, K. Bhalla

2015

Lenalidome in combination with rituximab for relapsed or refractory mantel cell lymphoma: Updated analysis of a phase 2 trial.

Yucai Wang, Maria Lourdes Dela Rosa, Shou-Hao Zhou, M. Badillo, A. Addison, Liang Zhang, Hun Lee, J. Romaguera, Michael Wang

2015

Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.

Baohua Sun, Bhavin Shah, W. Fiskus, J. Qi, K. Rajapakshe, C. Coarfa, Li Li, Santhana G. T. Devaraj, Sunil Sharma, Liang Zhang, Michael L. Wang, Dyana T. Saenz, Stephanie S. Krieger, J. Bradner, K. Bhalla

Blood

2015

Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update for a Phase II Clinical Trial

Michael L. Wang, Hun J. Lee, H. Chuang, N. Wagner-Bartak, F. Hagemeister, J. Westin, L. Fayad, F. Samaniego, F. Turturro, Wendy Chen, M. Badillo, K. Nomie, Maria Lourdes Dela Rosa, Dong-Lu Zhao, A. Addison, K. H. Young, R. Champlin, J. Romaguera, Liang Zhang

2015

CD4+ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma

Liang Zhang, Enguang Bi, Sungyoul Hong, J. Qian, Cheng-Yun Zheng, Michael L. Wang, Q. Yi

OncoTarget

2015

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.

Blood

2015

BET Protein Bromodomain Antagonist-Based Combinations Exert Synergistic Pre-Clinical Activity Against Ibrutinib-Sensitive or -Resistant Human Mantle Cell Lymphoma (MCL) Cells

Baohua Sun, W. Fiskus, Dyana T. Saenz, Stephanie S. Krieger, Liang Zhang, S. Parmar, Michael L. Wang, K. Bhalla

2015

A Phase II Study of MESA Chemotherapy for Newly Diagnosed, Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of Northern-West of China

R. Liang, Guang-Xun Gao, Chen Ping, Ji-Shi Wang, Xiao-Min Wang, Yun Zeng, Xie-Qun Chen, Liang Zhang

2015

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival

Kailin Chen, Jie Chen, H. Rao, Ying Guo, Hui-Qiang Huang, Liang Zhang, Jian-Yong Shao, Tong-Yu Lin, Wen-Qi Jiang, D. Zou, Li-Yang Hu, Michael Lucas Wirian, Qing-Qing Cai

Chinese journal of cancer

2014

忠诚于知识友谊的福柯想象——布朗肖《我所想象的米歇尔·福柯》解读

张亮

《苏州大学学报(哲学社会科学版)》，No. 4

2014

“怎么看”以及“怎么办”--“马工程”重点教材《马克思主义哲学》使用体会

张亮

《福建论坛(人文社会科学版)》，No. 7

2014

Peripheral Absolute Neutrophil, Mmonocyte and Lymphocyte Counts and Clinical Ooutcome in Diffuse Large B-Cell Lymphoma

Yiming Chen, M. Rodriguez, Lei Feng, Wei-Qi Bi, Liang Zhang, Michael L. Wang

2014

The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL

L. Pham, Archito T. Tamayo, E. Pogue, G. Lu, Pramoda Challagundla, J. Jorgensen, Liang Zhang, Michael L. Wang, R. Ford

2014

STAT3 Activation Is Preceded By Two Independent Pathways (BCR-BTK and IL6-JAK) in Mantle Cell Lymphoma

Hyebin Park, Dong-Lu Zhao, George Tsourdinis, Zhishuo Ou, Archito T. Tamayo, R. Ford, B. Fang, L. Pham, Liang Zhang, Michael L. Wang

2014

Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study

M. K. Garcia, L. Cohen, Ying Guo, Yu-Hong Zhou, B. You, Joseph S. Chiang, R. Orlowski, D. Weber, J. Shah, R. Alexanian, S. Thomas, J. Romaguera, Liang Zhang, M. Badillo, Yiming Chen, Q. Wei, Richard T. Lee, K. Delasalle, V. Green, Michael L. Wang

Journal of Hematology & Oncology

2014

Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective

M. Desai, K. Newberry, Zhishuo Ou, Michael L. Wang, Liang Zhang

Therapeutic Advances in Hematology

2014

Single-Agent Ibrutinib Demonstrates Safety and Durability of Response at 2 Years Follow-up in Patients with Relapsed or Refractory Mantle Cell Lymphoma: Updated Results of an International, Multicenter, Open-Label Phase 2 Study

Michael L. Wang, S. Rule, P. Martin, A. Goy, R. Auer, B. Kahl, W. Jurczak, R. Advani, J. Romaguera, Michael E. Williams, J. Barrientos, E. Chmielowska, J. Radford, S. Stilgenbauer, M. Dreyling, W. Jędrzejczak, P. Johnson, S. Spurgeon, Liang Zhang, L. Baher, M. Cheng, D. Beaupre, K. Blum

2014

Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease

L. Pham, Muychi T Vang, Archito T. Tamayo, G. Lu, Pramoda Challagundla, J. Jorgensen, Alex Rollo, Zhishuo Ou, Liang Zhang, Michael L. Wang, R. Ford

Leukemia and Lymphoma

2014

Coexpression of MYC and BCL-2 Predicts Inferior Survival in Pgi-DLBCL Treated with CHOP-like Regimen/Rituximab

Le Zhang, B. Xia, Shan-Qi Guo, Xiao-Wu Li, Fu-Lian Qu, Haifeng Zhao, Lian-Yu Zhang, Bao-cun Sun, Liang Zhang, Yi-Zhuo Zhang

2014

Ibrutinib and Rituximab Are an Efficacious and Safe Combination in Relapsed Mantle Cell Lymphoma: Preliminary Results from a Phase II Clinical Trial

Michael L. Wang, F. Hagemeister, J. Westin, L. Fayad, F. Samaniego, F. Turturro, Wendy Chen, Liang Zhang, M. Badillo, Maria Lourdes Dela Rosa, A. Addison, L. Kwak, J. Romaguera

2014

Potent Inhibition of the Growth and Induction of Apoptosis of Mantle Cell Lymphoma By the Novel Anthracycline Berubicin in Vitro and in Vivo

George Tsourdinis, Hyebin Park, Luhong Sun, I. Fokt, A. Jayakumar, Hui Zhang, Q. Cai, D. Zou, B. Fang, W. Priebe, Michael L. Wang, Liang Zhang

2014

Accelerated therapeutic progress in diffuse large B cell lymphoma

Q. Cai, J. Westin, K. Fu, M. Desai, Liang Zhang, Hui-Qiang Huang, Wen-Qi Jiang, R. Liang, Z. Qian, R. Champlin, Michael L. Wang

Annals of Hematology

2014

Anti-CD20 and B-Cell Receptor-Mediated Growth Inhibition and Apoptosis: A Preclinical Study of Ibrutinib and Rituximab Combination Therapy in Mantle Cell Lymphoma in Vitro and in Vivo

Liang Zhang, Hui Zhang, Dong-Lu Zhao, George Tsourdinis, Hyebin Park, Archito T. Tamayo, L. Pham, R. Ford, B. Fang, Michael L. Wang

2014

Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma

Q. Cai, Yiming Chen, D. Zou, Liang Zhang, M. Badillo, Shou-Hao Zhou, E. Lopez, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, J. Romaguera, Michael L. Wang

OncoTarget

2013

福柯、阿多诺和跨文化研究观念——纪念阿多诺诞辰110周年

张亮

《学术研究》，No. 10

2013

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael L. Wang, S. Rule, P. Martin, A. Goy, R. Auer, B. Kahl, W. Jurczak, R. Advani, J. Romaguera, Michael E. Williams, J. Barrientos, E. Chmielowska, J. Radford, S. Stilgenbauer, M. Dreyling, W. Jędrzejczak, P. Johnson, S. Spurgeon, Lei Li, Liang Zhang, K. Newberry, Zhishuo Ou, N. Cheng, B. Fang, J. Mcgreivy, Fong Clow, J. Buggy, B. Chang, D. Beaupre, L. Kunkel, K. Blum

New England Journal of Medicine

2013

Abstract 2432: The bruton's tyrosine kinase inhibitor ibrutinib synergized with the proteasome inhibitor carfilzomib and overcame immunoproteasome-mediated carfilzomib resistance in mantle cell lymphoma .

Zhishuo Ou, Liang Zhang, K. Newberry, Luhong Sun, K. Christopher, Alex Rollo, Archito T. Tamayo, John Lee, R. Ford, Michael L. Wang, L. Pham

2013

In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Liang Zhang, L. Pham, K. Newberry, Zhishuo Ou, R. Liang, J. Qian, Luhong Sun, M. Blonska, Y. You, Jing Yang, Xin Lin, Alex Rollo, Archito T. Tamayo, John Lee, R. Ford, Xiu-Rong Zhao, L. Kwak, Q. Yi, Michael L. Wang

Molecular Cancer Therapeutics

2013

Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment

Liang Zhang, K. Newberry, Michael Wang

Expert Review of Clinical Immunology

2013

Selective Inhibitor Of Nuclear Exports (SINE) KPT-330 In Combination With The Novel Proteasome Inhibitor Carfilzomib As a Novel Therapeutic Regimen For Treating Aggressive B-Cell Lymphomas

E. Lopez, Erin M Dominici, Muychi T Vang, Archito T. Tamayo, Zhishuo Ou, Alex Rollo, Liang Zhang, Jack Wang, L. Strickland, C. Kirk, M. Kauffman, S. Shacham, Michael L. Wang, L. Pham, R. Ford

2013

Targeting BCR Activated STAT3 By Ibrutinib In Mantle Cell Lymphoma

L. Pham, Muychi T Vang, Liang Zhang, Jack Wang, L. Strickland, E. Lopez, Erin M Dominici, Alex Rollo, Archito T. Tamayo, R. Ford, Michael L. Wang

2013

Ibrutinib Overcomes Carfilzomib Resistance In Immunoproteasome-Deficient Mantle Cell Lymphoma

Liang Zhang, Zhishuo Ou, Jack Wang, Erin M Dominici, Hui Zhang, R. Ford, Michael L. Wang, L. Pham

2013

Carfilzomib, a Second-Generation Proteasome Inhibitor, In Combination With The Btk Inhibitor Ibrutinib As a Novel Therapeutic Regimen For Treating Double Hit DLBCL

E. Lopez, Muychi T Vang, Archito T. Tamayo, Zhishuo Ou, Alex Rollo, Liang Zhang, Jack Wang, L. Strickland, Michael L. Wang, R. Ford, L. Pham, C. Kirk

2013

Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy

M. Desai, K. Newberry, J. Romaguera, Liang Zhang, Zhishuo Ou, Michael L. Wang

Journal of Hematology & Oncology

2013

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

Michael L. Wang, N. Fowler, N. Wagner-Bartak, Lei Feng, J. Romaguera, S. Neelapu, F. Hagemeister, M. Fanale, Y. Oki, B. Pro, J. Shah, S. Thomas, A. Younes, C. Hosing, Liang Zhang, K. Newberry, M. Desai, N. Cheng, M. Badillo, M. Bejarano, Yiming Chen, K. Young, R. Champlin, L. Kwak, L. Fayad

Leukemia

2013

The Role Of Mir-155 In Controlling Key Growth and Survival Pathways In ABC-Subtype DLBCL

L. Pham, Muychi T Vang, Archito T. Tamayo, Zhishuo Ou, Alex Rollo, Liang Zhang, Erin M Dominici, E. Lopez, James S. Pham, Jack Wang, L. Strickland, Michael L. Wang, R. Ford

2013

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Q. Cai, Yiming Chen, D. Zou, M. Badillo, Shou-Hao Zhou, Liang Zhang, E. Lopez, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Michael L. Wang

2013

Abstract 3961: IL-15 improves the effect of adoptive T cell therapy through cellular senescence delay.

J. Weng, Sung‐Doo Kim, Haiyan S Li, Jin He, J. Qian, H. Torikai, Liang Zhang, Jing Yang, Q. Yi, L. Kwak

2013

Clinical Analysis Of 120 Cases Of Natural Killer/T Cell Lymphoma, Nasal Type By Single Hospital In The North-Western China

R. Liang, Xie-Qun Chen, Zhe Wang, Bai-Qing Xian, Qin-Guo-Guo Yan, Lan Yang, Tao Zhang, Hong-Tao Gu, Bao-Xia Dong, Guang-Xun Gao, Mi-Mi Shu, Liang Zhang

2013

Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.

Kejie Zhang, Michael L. Wang, Archito T. Tamayo, S. Shacham, M. Kauffman, John Lee, Liang Zhang, Zhishuo Ou, Chang-Ping Li, Luhong Sun, R. Ford, L. Pham

Experimental Hematology

2013

Abstract 3389: Nuclear accumulation of c-Rel transcription factor is correlated with the proteasome inhibitor resistance in mantle cell lymphoma.

M. Blonska, D. Pan, Zhishuo Ou, Liang Zhang, Xin Lin, Michael L. Wang

2013

Drug Screening Reveals That Ibrutinib (PCI-32765) Exhibits Synergy With BCL-2 and Proteasome Inhibitors In Models Of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)

M. Axelrod, Zhishuo Ou, Liang Zhang, Vicki L. Gordon, E. Lopez, Archito T. Tamayo, R. Ford, L. Pham, Michael J. Weber, Michael E. Williams, Michael L. Wang

2012

“英国马克思主义”的历史、理论道路与理论成就

张亮

《马克思主义研究》，No. 7

2012

马克思主义理论——文化批判理论笔谈——“英国马克思主义”的“文化唯物主义”及其当代评价

张亮

《河海大学学报(哲学社会科学版)》，Vol. 14, No. 4

2012

在多极化、多元化格局中坚持马克思主义

张亮

《南京工业大学学报：社会科学版》，Vol. 11, No. 4

2012

Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.

Luhong Sun, Liang Zhang, J. Qian, Jing Yang, Q. Yi, W. Dong, Michael L. Wang

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

2012

Study On the Expression of 14-3-3ζ in Acute Myeloid Leukemic Cell Lines

R. Liang, H. Xiong, Zhe Wang, Qun-Xie Chen, Xun-Guang Gao, Xia-Bao Dong, Liang Zhang

2012

Effect of berubicin, the 4'-o-benzylated doxorubicin analog, on growth inhibition and apoptosis in multiple myeloma.

Michael L. Wang, Luhong Sun, I. Fokt, Liang Zhang, A. Jayakumar, W. Priebe

2012

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.

Michael Wang, L. Fayad, N. Wagner-Bartak, Liang Zhang, F. Hagemeister, S. Neelapu, F. Samaniego, P. Mclaughlin, M. Fanale, A. Younes, F. Cabanillas, N. Fowler, K. Newberry, Luhong Sun, K. Young, R. Champlin, L. Kwak, Lei Feng, M. Badillo, M. Bejarano, K. Hartig, Wendy Chen, Yiming Chen, C. Byrne, N. Bell, J. Zeldis, J. Romaguera

The Lancet Oncology

2012

Biological Significance of the Immumoproteasome Subunits Mecl-1 and LMP-2 in Diffuse Large B-Cell Lymphoma.

L. Pham, Alex Rollo, Archito T. Tamayo, John Lee, Z. Zuo, Luhong Sun, Liang Zhang, Zhi-Shou Ou, L. Fayad, Michael L. Wang, R. Ford

2012

Abstract 2854: Targeting constitutive NF-kB activation through Bruton's tyrosine kinase (Btk) and the proteasome in mantle cell lymphoma

Zhishuo Ou, Archito T. Tamayo, Liang Zhang, John Lee, Kejie Zhang, Chang-Ping Li, Jacqueline F. Wang, James S. Pham, Luhong Sun, C. Kirk, R. Ford, L. Pham

2011

Novel CRM-1 Inhibitors for Therapy In Mantle Cell Lymphoma

Kejie Zhang, L. Pham, Liang Zhang, Archito T. Tamayo, Zhishuo Ou, D. Mccauley, S. Shacham, M. Kauffman, R. Ford, Michael L. Wang

2011

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

Yuhuan Zheng, Jing Yang, J. Qian, Liang Zhang, Yong Lu, Haiyan S Li, Heather Y. Lin, Y. Lan, Zhiqiang Liu, Jin He, Sungyoul Hong, S. Thomas, J. Shah, V. Baladandayuthapani, L. Kwak, Q. Yi

Journal of molecular medicine

2011

Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo.

Z. Qian, Liang Zhang, Z. Cai, Luhong Sun, Huaqing Wang, Q. Yi, Michael L. Wang

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

2011

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Liang Zhang, J. Qian, Zhishuo Ou, Luhong Sun, Kejie Zhang, L. Pham, C. Kirk, R. Ford, Q. Yi, Michael L. Wang

2011

Single-Agent Bruton's Tyrosine Kinase (Btk) Inhibitor and Single-Agent Carfilzomib Induce Cell Apoptosis, Arrest Cell Growth and Downregulate NF-Kb Activity In Mantle Cell Lymphoma

Zhishuo Ou, L. Pham, Liang Zhang, Archito T. Tamayo, John Lee, Kejie Zhang, Jacqueline F. Wang, James Phan, Chang-Ping Li, Luhong Sun, R. Ford, Michael L. Wang

2010

正确处理西方马克思主义哲学研究中的三种关系

张亮

《理论探讨》，No. 5

2010

20世纪上半叶西方学者的马克思传记建构：批判的评论

张亮

《马克思主义研究》，No. 5

2010

在哲学政治化的起点上——重读斯大林1930年12月9日的谈话

张亮

《山东社会科学》，No. 11

2010

Active Vaccination with DKK1 Induces Protective and Therapeutic Antitumor Immunity In Multiple Myeloma

J. Qian, Sungyoul Hong, H. Qin, Ji Wang, Jin-Song Wei, Liang Zhang, Haiyan S Li, Yuhuan Zheng, Y. Lan, Jing Yang, Yong Lu, L. Kwak, Q. Yi

2010

Effect of a combination of atiprimod and the proteasome inhibitor bortezomib on apoptosis of mantle cell lymphoma in vitro and in vivo.

Mo-Lin Wang, Liang Zhang, Luhong Sun, J. Qian, J. Yang, Q. Yi

2010

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

Liang Zhang, Jing Yang, J. Qian, Haiyan S Li, J. Romaguera, L. Kwak, Michael L. Wang, Q. Yi

Blood

2010

Abstract 2629: Carfilzomib, an irreversible proteasome inhibitor, induces caspase-dependent apoptosis and inhibits the growth of mantle cell lymphomain vitroand in tumor-bearing SCID mice

Liang Zhang, J. Qian, Jing Yang, M. Aujay, S. Demo, Q. Yi, Michael L. Wang

2010

Novel PI3K Inhibitor Compound A Induces Myeloma Cell Apoptosis and Shows Synergistic Cytotoxicity with Dexamethasone In Multiple Myeloma

Yuhuan Zheng, Jing Yang, Liang Zhang, J. Qian, J. Matthews, Michael L. Wang, L. Kwak, Q. Yi

2010

572 Berubicin, a topoisomerase II poison with high CNS uptake, inhibits cell growth and induces apoptosis in diffuse large B-cell lymphomas

W. Priebe, Michael L. Wang, Luhong Sun, I. Fokt, H. Bao, Liang Zhang, A. Jayakumar

2009

法兰克福学派的批判理论与政治经济学

张亮

《天津社会科学》，No. 4

2009

我国马克思主义哲学史学科的历史之路

张亮

《学术研究》，No. 1

2009

国内卢卡奇研究的两种模式及其超越

张亮

《河北学刊》，Vol. 29, No. 4

2009

波洛克国家资本主义批判理论的形成及其效应

陈湘珍，张亮

《理论探讨》

2009

日本马克思主义的当代发展——访日本立命馆大学小堀眞裕教授

张亮

《国际社会科学杂志》

2009

Targeting DKK1 for the Immunotherapy of B-Cell Lymphomas.

J. Qian, Sungyoul Hong, Liang Zhang, Yuhuan Zheng, Haiyan S Li, Jing Yang, S. Neelapu, Q. Yi

2009

CYCLIN D1 AS A UNIVERSALLY-EXPRESSED MANTLE CELL LYMPHOMA-ASSOCIATED TUMOR ANTIGEN FOR IMMUNOTHERAPY

Michael Wang, Luhong Sun, J. Qian, Xiao-Hong Han, Liang Zhang, P. Lin, Zhen Cai, Qing Yi

Leukemia

2009

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

J. Qian, Sungyoul Hong, Siqing Wang, Liang Zhang, Luhong Sun, Michael L. Wang, Jing Yang, L. Kwak, Jian Hou, Q. Yi

Blood

2009

Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

Liang Zhang, Z. Qian, Z. Cai, Luhong Sun, Huaqing Wang, J. Bartlett, Q. Yi, Michael L. Wang

American journal of hematology/oncology

2008

中国马克思主义哲学史研究的范式生成与转换

张亮

《中国社会科学》，No. 4

2008

汤普森与英国马克思主义的文化转向

张亮

《南京大学学报(哲学.人文科学.社会科学)》，Vol. 45, No. 5

2008

汤普森“文化唯物主义”的理论与范式

张亮

《吉林大学社会科学学报》，Vol. 48, No. 5

2008

汤普森的阶级斗争分析方法与阶级决定论

张亮

《南京社会科学》，No. 8

2008

汤普森阶级意识学说的当代审视

张亮

《社会科学辑刊》

2008

爱德华·P·汤普森的工人阶级形成学说：批判的再考察

张亮

《山东社会科学》，No. 10

2008

汤普森视域中的民族性与马克思主义

张亮

《福建论坛(人文社会科学版)》，No. 7

2008

Cancer Cell Line–Derived, Pooled Heat Shock Proteins as a Potential Universal Vaccine for Immunotherapy of Cancer

J. Qian, Sungyoul Hong, Siqing Wang, Liang Zhang, L. Kwak, Q. Yi

2008

Cyclin D1 as a Universally-Expressed Mantle Cell Lymphoma-Associated aTumor Antigen for Immunotherapy

Michael L. Wang, Luhong Sun, J. Qian, Xiao-Hong Han, Liang Zhang, P. Lin, Q. Yi

2008

Immunotherapy in mantle cell lymphoma: Anti‐CD20‐based therapy and beyond

Yu-Hong Zhou, Liang Zhang, J. Romaguera, K. Delasalle, Xiao-Hong Han, Xin Du, L. Kwak, Q. Yi, Michael L. Wang

American journal of hematology/oncology

2008

A Severe Combined Immunodeficient–hu In vivo Mouse Model of Human Primary Mantle Cell Lymphoma

Michael L. Wang, Liang Zhang, Xiao-Hong Han, Jing Yang, J. Qian, Sungyoul Hong, P. Lin, Yuan-Kai Shi, J. Romaguera, L. Kwak, Q. Yi

Clinical Cancer Research

2008

Lenalidomide and Rituximab Are a Promising Combination in Vitro, in Vivo Preclinically and in a Phase I/II Clinical Trial in Relapsed/Refractory Mantle Cell Lymphoma

Michael L. Wang, Liang Zhang, L. Fayad, F. Hagemeister, S. Neelapu, F. Samaniego, B. Pro, A. Younes, Scott A. Miller, R. Knight, J. Zeldis, Q. Yi, J. Romaguera

2007

国内近期“后马克思主义”研究简评

张亮

《哲学动态》，No. 2

2007

Anti-β2-Microglobulin Monoclonal Antibodies Recruit MHC Class I to and Exclude Growth and Survival Cytokine Receptors from Lipid Rafts and Induce Apoptosis in Myeloma Cells.

Jing Yang, Xiang Zhang, Ji Wang, J. Qian, Songyoul Hong, Liang Zhang, Luhong Sun, Michael L. Wang, L. Kwak, Q. Yi

2007

A SCID-hu In Vivo Mouse Model of Human Primary Mantle Cell Lymphoma.

Michael L. Wang, Yuan-Kai Shi, Liang Zhang, Xiao-Hong Han, Jing Yang, J. Qian, Sungyoul Hong, P. Lin, J. Romaguera, L. Kwak, Q. Yi

2007

Bortezomib Is Synergistic with Rituximab and Cyclophosphamide in Inducing Apoptosis of Mantle Cell Lymphoma Cells In Vitro and In Vivo.

Liang Zhang, Yuan-Kai Shi, Xiao-Hong Han, Jing Yang, J. Qian, L. Kwak, J. Romaguera, Q. Yi, Michael L. Wang

2007

Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal While Th2 Cells Promote Tumor Growth.

Sungyoul Hong, J. Qian, Jing Yang, Liang Zhang, Xiang Zhang, Ji Wang, Qing Yi

2007

DKK1-Specific Cytotoxic T Lymphocytes Are Potent Effector Cells for the Treatment of Multiple Myeloma in SCID-hu Model.

J. Qian, Liang Zhang, Sungyoul Hong, Ji Wang, L. Kwak, Q. Yi

2007

Anti-β2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts

Jing Yang, Xiang Zhang, Ji Wang, J. Qian, Liang Zhang, Michael L. Wang, L. Kwak, Q. Yi

2007

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

J. Qian, Jin Xie, Sungyoul Hong, Jing Yang, Liang Zhang, Xiao-Hong Han, Michael L. Wang, F. Zhan, J. Shaughnessy, J. Epstein, L. Kwak, Q. Yi

Blood

2006

从学科意识到问题意识（笔谈）——当代马克思主义哲学研究范式转换研究——苏联马克思主义哲学研究的“学科意识”之痛

张亮

《天津社会科学》，No. 3

2006

在转向唯物主义和共产主义的前夜——《莱茵报》时期马克思哲学思想发展的再考察

张亮

《华中科技大学学报(社会科学版)》，Vol. 20, No. 4

2006

“理想主义”哲学世界观的立与破——马克思大学时代诗作的哲学解读

张亮

《求是学刊》，Vol. 33, No. 1

2006

英国马克思主义的研究模式及方法

张亮

《求是学刊》，Vol. 33, No. 5

2006

从“西方马克思主义”到西方“马克思学”——诺曼·莱文教授访谈录

诺曼·莱文[美]，张亮

《南京大学学报(哲学·人文科学·社会科学)》

2006

西方“马克思学”的兴起、演化与终结

张亮

《福建论坛(人文社会科学版)》，No. 4

2006

Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

Michael L. Wang, Liang Zhang, Xiao-Hong Han, Jing Yang, J. Qian, Sungyoul Hong, F. Samaniego, J. Romaguera, Q. Yi

Blood

2006

C-Reactive Protein Binds to FcγRII and Impairs the Differentiation and Function of Dendritic Cells.

J. Qian, Jing Yang, Siqing Wang, Liang Zhang, Sungyoul Hong, Xiao-Hong Han, Q. Yi

2006

C-Reactive Protein Protects Myeloma Cells from Apoptosis Via Activating ITAM-Containing Fcγ RII.

Jing Yang, Michele J. Wezeman, Xiang Zhang, J. Qian, Songyoul Hong, Xiao-Hong Han, Liang Zhang, L. Kwak, Q. Yi

2006

Use of bortezomib in B-cell non-Hodgkin’s lymphoma

Michael L. Wang, Yu-Hong Zhou, Liang Zhang, C. Nguyen, J. Romaguera

Expert Review of Anticancer Therapy

2005

恩格斯：马克思主义哲学史研究的第一推动力

张亮

《南京大学学报(哲学.人文科学.社会科学)》，Vol. 42, No. 1

2005

传统马克思哲学研究模式的历史形成：一种知识社会学审理

张亮

《学术月刊》，No. 12

2005

西方“马克思学”的恩格斯研究：一个批判的评价

张亮

《教学与研究》，No. 8

2005

马克思主义哲学形成史传统分期模式的形成及其评价

张亮

《理论探讨》

2004

“马克思哲学与当代国外马克思主义最新进展”学术研讨会综述

张亮，胡大平

《马克思主义研究》，No. 1

2004

中国西方马克思主义哲学研究的逻辑转换

张一兵，胡大平，张亮

《中国社会科学》，No. 6

2004

晚期马克思主义视域中的“晚期资本主义”：一种历史考察

张亮

《南京大学学报(哲学.人文科学.社会科学)》，Vol. 41, No. 5

2004

从马克思哲学到当代国外马克思主义——第三届“马克思哲学论坛”综述

胡大平，张亮

《哲学研究》，No. 2

2004

黑格尔的市民社会理论及其现代意义

陈湘珍，张亮

《南京社会科学》

2004

欲望、死亡与承认：科耶夫式黑格尔哲学的三个关键词

张亮

《江苏社会科学》，No. 3

2003

从激进乐观主义到现实主义——佩里·安德森与《新左派评论》杂志的理论退却

张亮

《马克思主义研究》，No. 2

2003

作为思潮的“晚期马克思主义”

张亮

《南京大学学报(哲学.人文科学.社会科学)》，Vol. 40, No. 2

2003

国内卢卡奇研究七十年：一个批判的回顾

张亮

《现代哲学》，No. 4

2003

走出思想史阴影的齐美尔－－兼评《格奥尔格·齐美尔：现代性的诊断》

张亮

《社会》，No. 4

2002

西方马克思主义哲学研究的方法论问题－－兼评张一兵的《无调式的辩证想象》

张亮

《天津社会科学》，No. 5

2002

哲学革命在经济学语境中的真实再现－－评唐正东的《斯密到马克思》

张亮

《南京社会科学》，No. 12

2002

马克思和《精神现象学》－－一个历史主义的文本学分析

张亮

《南京大学学报(哲学.人文科学.社会科学)》，Vol. 39, No. 2

2002

内在解读：马克思主义哲学研究必需的方法论自觉

张亮

《学术月刊》，No. 6

2002

克尔凯郭尔、内在性与唯心主义问题——读阿多诺的《克尔凯郭尔：审美对象的建构》

张亮

《福建论坛(人文社会科学版)》，No. 2

2002

第一哲学的神话:阿多诺对胡塞尔先验现象学的三个追问

张亮

《理论探讨》，No. 5

2002

胡塞尔逻辑绝对主义的马克思主义批判－－读阿多诺的《认识论的元批判》

张亮

《社会科学战线》，No. 6

2001

确立“新的社会主义分配观”

张亮

《社会主义研究》，No. 5

2001

德国当代哲学的逻辑发展与“哲学的现实性”——青年阿多诺的哲学思想

张亮

《南京社会科学》，No. 10

2001

“否定的辩证法”的忘却:阿多诺研究的历史性遮蔽

张亮

《浙江社会科学》

2000

阿多诺与西方马克思主义的逻辑终结

张亮

《福建论坛(人文社会科学版)》，No. 4

1999

《精神现象学》的使命和体系:一个再考察

张亮

《理论探讨》，No. 3

1999

走向“历史的”唯物主义——马克思1843年间思想发展的内在逻辑

张亮

《甘肃社会科学》，No. 6

1998

谁的“思维着的新世界观”?──评丛大川先生的《1844年经济学哲学手稿》研究

张亮

《福建论坛(人文社会科学版)》，No. 4

1998

“马克思的人学”及对它的经济学解读──“纪念《1844年经济学哲学手稿》公开发表65周年学术研讨会”述记

张亮

《江苏社会科学》，No. 3

1998

是物质实体,还是社会经济关系?──论青年马克思对唯物主义范畴的矛盾理解

张亮

《南京大学学报(哲学.人文科学.社会科学)》，No. 1

1997

交往范畴的科学定位──《德意志意识形态》中的交往范畴

张亮

《理论探讨》，No. 3

1997

对象化“反对”异化——评《1844年经济学—哲学手稿》中的一个潜在矛盾悖结

张亮

《南京社会科学》，No. 4